Kineta - 8 Year Stock Price History | KANT
Historical daily share price chart and data for Kineta since 2016 adjusted for splits and dividends. The latest closing stock price for Kineta as of September 18, 2024 is 0.57.
- The all-time high Kineta stock closing price was 402.00 on June 10, 2016.
- The Kineta 52-week high stock price is 5.39, which is 845.6% above the current share price.
- The Kineta 52-week low stock price is 0.33, which is 42.1% below the current share price.
- The average Kineta stock price for the last 52 weeks is 1.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Kineta Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
1.0636 |
3.4000 |
3.4000 |
0.3400 |
0.5746 |
-84.17% |
| 2023 |
3.8214 |
6.2250 |
8.3300 |
1.8400 |
3.6300 |
-42.83% |
| 2022 |
1.7568 |
3.2700 |
6.3500 |
0.9700 |
6.3500 |
114.53% |
| 2021 |
12.6819 |
17.9500 |
22.5200 |
2.8100 |
2.9600 |
-82.59% |
| 2020 |
27.6280 |
43.6000 |
46.2000 |
16.6700 |
17.0000 |
-62.72% |
| 2019 |
34.9319 |
69.4000 |
89.2000 |
12.6000 |
45.6000 |
-29.63% |
| 2018 |
80.8267 |
123.8000 |
207.0000 |
35.0000 |
64.8000 |
-44.43% |
| 2017 |
118.1622 |
253.0000 |
326.2000 |
31.2000 |
116.6000 |
-52.45% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
|
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|
